Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Web Resources
|
Effect of asthma and asthma medication on the prognosis of patients with COVID-19European Respiratory Journal, 2020, Vol.57 (3), p.2002226 [Peer Reviewed Journal]Copyright ©ERS 2021. ;2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright ©ERS 2021 2021 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.02226-2020 ;PMID: 32978309Digital Resources/Online E-Resources |
|
2 |
Material Type: Web Resources
|
Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failureEuropean Respiratory Journal, 2020, Vol.57 (2), p.2002524 [Peer Reviewed Journal]2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright ©ERS 2021 2021 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.02524-2020 ;PMID: 33033151Digital Resources/Online E-Resources |
|
3 |
Material Type: Web Resources
|
Le médicament du mois. La finérénone (Kerendia®), une nouvelle arme contre la maladie rénale chronique du patient avec diabète de type 2ISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 38095038Full text available |
|
4 |
Material Type: Web Resources
|
Inflammation et cancer : une relation complexe à double sensISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 35657194Full text available |
|
5 |
Material Type: Web Resources
|
Obésité, diabète de type 2, syndrome métabolique : quel est l’impact métabolique des antidépresseurs ?ISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 37712162Full text available |
|
6 |
Material Type: Web Resources
|
Nouveautés dans la prise en charge des maladies inflammatoires chroniques intestinalesISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 35657190Full text available |
|
7 |
Material Type: Web Resources
|
Médicaments anti-obésité : des déceptions aux espoirsISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 36924152Full text available |
|
8 |
Material Type: Web Resources
|
Wnt inhibitors reduce the unfolded protein response and enhance bortezomib-induced cell death in multiple myelomainfo:eu-repo/semantics/OpenAccess ;ISSN: 2473-9529 ;EISSN: 2473-9537Full text available |
|
9 |
Material Type: Web Resources
|
Une nouvelle ère pour les agonistes des récepteurs du glucagon-like peptide-1ISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 36634066Full text available |
|
10 |
Material Type: Web Resources
|
À propos de la sécurité d’emploi des inhibiteurs des SGLT2 (gliflozines)ISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 35389005Full text available |
|
11 |
Material Type: Web Resources
|
Actualites therapeutiques 2003-2004ISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 15346977Full text available |
|
12 |
Material Type: Web Resources
|
Administration of Medications in Wisconsin SchoolsWisconsin Department of Public Instruction, 2022Digital Resources/Online E-Resources |
|
13 |
Material Type: Web Resources
|
Anticoagulation des patients diabétiques avec fibrillation auriculaire non valvulaireISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 33543854Full text available |
|
14 |
Material Type: Web Resources
|
Inhibiteurs des SGLT2 : nouvelle option pour prévenir ou traiter l’insuffisance cardiaqueISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 33830688Full text available |
|
15 |
Material Type: Web Resources
|
Inhibiteurs des SGLT2 chez les patients avec insuffisance rénale chronique : des essais contrôlés aux recommandations internationales et perspectives en pratique cliniqueISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 33682388Full text available |
|
16 |
Material Type: Web Resources
|
Inhibiteurs des SGLT2: focus sur le rein et la néphroprotectionISSN: 1660-9379 ;PMID: 34431632Full text available |
|
17 |
Material Type: Web Resources
|
Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedemainfo:eu-repo/semantics/OpenAccess ;ISSN: 0105-4538 ;EISSN: 1398-9995Digital Resources/Online E-Resources |
|
18 |
Material Type: Web Resources
|
Vignette thérapeutique de l’étudiant. Patient avec un diabète de type 2, une coronaropathie et une insuffisance cardiaqueISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 38602215Full text available |
|
19 |
Material Type: Web Resources
|
Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibitioninfo:eu-repo/semantics/OpenAccess ;ISSN: 0390-6078 ;EISSN: 1592-8721Full text available |
|
20 |
Material Type: Web Resources
|
Le médicament du moisMavacamten (Camzyos®) : premier inhibiteur réversible de l’ATP-ase de la myosine pour le traitement des cardiomyopathies hypertrophiques obstructivesISSN: 2566-1566 ;ISSN: 0370-629X ;PMID: 38356430Full text available |